Premium
Palifermin‐induced acral erythrodysaesthesia variant in the treatment of acute myeloid leukaemia
Author(s) -
Milne Olivia,
Cutts Briony,
McLean Catriona,
Gin Douglas
Publication year - 2011
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/j.1440-0960.2010.00682.x
Subject(s) - medicine , mucositis , myeloid leukaemia , chemotherapy , induction chemotherapy , myeloid , oncology , dermatology
ABSTRACT The recombinant human keratinocyte growth factor, palifermin, offers a potential means of reducing or preventing mucositis in patient undergoing intensive cancer treatments. This case report details the development of acral erythrodysaesthesia in one patient who underwent palifermin treatment prior to high‐intensity re‐induction chemotherapy for acute myeloid leukaemia.